B型肝炎ウイルス（HPV）治療市場：現在・未来プレイヤー...市場調査レポートについてご紹介

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers – Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Gilead
4.3.2 Bristol-Myers Squibb
4.3.3 Roche
4.3.4 Merck
4.3.5 GSK
4.3.6 Novartis
4.3.7 Arrowhead Research
4.3.8 GlobeImmune
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Total Prevalent Cases of Chronic Hepatitis B
5.4.2 Diagnosed Chronic Hepatitis B Patients
5.4.3 Percent Drug-Treated Chronic Hepatitis B Patients
5.4.4 Drugs Included in Each Therapeutic Class
5.4.5 Launch and Patent Expiry Dates
5.4.6 General Pricing Assumptions
5.4.7 Individual Drug Assumptions
5.4.8 Generic Erosion
5.4.9 Pricing of Pipeline Agents
5.5 Primary Research – KOLs Interviewed for this Report
5.6 Primary Research – Prescriber Survey
5.7 About the Authors
5.7.1 Analyst
5.7.2 Therapy Area Director
5.7.3 Epidemiologists
5.7.4 Global Director of Therapy Analysis and Epidemiology
5.7.5 Global Head of Healthcare
5.8 About GlobalData
5.9 Disclaimer